ESR1 and breast cancer: In this study, Chidamide is applied to estrogen receptor (ER) positive MCF-7 and triple-negative MDA-MB-231 breast cancer cells in order to explore the role of LncRNA in the regulatory mechanism in breast cancer growth inhibition.